GlassScriptPhysician profile
Ajay Pachika
NPI 1477566248
$11,143.05
in general payments reported to CMS, 2019-2025
33 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $1,933 · 2021: $1,480 · 2022: $1,344 · 2023: $1,618 · 2024: $1,219 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,110 · Travel and Lodging: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,110.25 |
| Travel and Lodging | $463.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,942.92 | 2019-2025 | Triclip, Mitraclip, 2nd Gen Centrimag Primary Console |
| Novartis Pharmaceuticals Corporation | $1,625.92 | 2019-2025 | |
| Medtronic Vascular, INC. | $1,137.53 | 2020 | |
| Amgen INC. | $950.33 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $931.44 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $669.62 | 2019-2025 | Farxiga, Lokelma |
| Merck Sharp & Dohme LLC | $668.60 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $499.59 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.06 | 2020-2025 | Jardiance |
| Medtronic, INC. | $385.61 | 2021-2025 | Symplicity G3, Viance, Turbohawk |
| E.R. Squibb & Sons, L.L.C. | $342.03 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $236.93 | 2019-2024 | |
| Inari Medical, INC. | $235.27 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $170.73 | 2022-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $160.52 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $111.70 | 2024-2025 | Nexletol |
| Stryker Corporation | $88.94 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $83.71 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $75.04 | 2022-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $65.61 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $48.24 | 2019-2020 | |
| Irhythm Technologies, INC. | $40.09 | 2024 | Zio Monitor, Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $37.11 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $24.68 | 2025 | |
| Boston Scientific Corporation | $22.86 | 2022 | |
| Emd Serono, INC. | $22.00 | 2025 | |
| Novo Nordisk INC | $21.32 | 2025 | Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $21.09 | 2023 | Onpattro |
| Inspire Medical Systems, INC. | $17.58 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $16.68 | 2024 | Opsumit, Uptravi |
| Philips North America LLC | $14.82 | 2025 | Ecc Solutions |
| Kowa Pharmaceuticals America, INC. | $12.64 | 2022 | |
| Cmp Pharma, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Pachika listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.